Retrieved December 2, 2014 's Authorization A/V & 2534 determines the extension stocks relative to medicine: NASAL packings: 040282016 ACTIGRIP-"1 Mg/Ml Nasal Spray, solution 1 Vial 10 Ml Hdpe Mah: JOHNSON and JOHNSON SPA 1. It is authorized, as of the date of entry into force of this determination, kept on the market of packaging already produced, until the expiration date printed on the label of the medicine, after delivery by pharmacists to reviewers, leaflet updated, in accordance with the provisions of art. 1, 2 and 3, paragraph 1 of the determination of the Director-General of AIFA on "criteria for the application of the provisions on the disposal of stocks of medicines # 371 of April 14, 2014, adopted, pursuant to art. 37 of Legislative Decree No. 219/2006, as amended by art. 44, paragraph 4-quinquies of Decree-Law No 69 June 21, 2013, bearing: "urgent measures for economic recovery", converted, with amendments, into law No 98 August 9, 2013, published in the official journal, General series, # 101 of May 3, 2014, effective as from June 3, 2014.
2. In compliance with the provisions referred to in the preceding subparagraph 1, pharmacists are required to deliver the package leaflet updated users as from the end of 30 days from the date of publication in the Official Gazette of the Italian Republic of this determination. The mAh makes accessible to pharmacist leaflet updated within the same timeframe.
Date of determination: from the day following that of its publication, to decompress, in Gazzetta Ufficiale della Repubblica italiana.